Annual revenue rose from KRW 14.1 trillion in 2022 to KRW 15.2 trillion in 2023 (up 7.4% year on year) and KRW 15.8 trillion in 2024 (up 3.9%), then fell to KRW 15.5 trillion in 2025 (down 1.4%). Among 2022 to 2025, 2024 was the largest year for revenue and 2022 the smallest.
Operating profit was KRW 493.7 billion in 2023 (up 0.8% year on year), the largest of the four years, and then declined for two consecutive years to KRW 340.5 billion in 2024 (down 31.0%) and KRW 239.4 billion in 2025 (down 29.7%).
The operating margin narrowed from 3.5% in 2022 and 3.3% in 2023 to 2.2% in 2024 and 1.5% in 2025, so margins thinned while revenue stayed near KRW 15 trillion.
Net income attributable to controlling shareholders swung from a KRW 170.8 billion profit in 2022 to a KRW 15.4 billion loss in 2023, widened to a KRW 1.02 trillion loss in 2024, and narrowed to a KRW 647.6 billion loss in 2025, marking three consecutive loss-making years.
Net income including non-controlling interests was a loss of KRW 946.1 billion in 2024 and a loss of KRW 595 billion in 2025. In 2025 the loss attributable to controlling shareholders was larger than the total net loss, which implies that non-controlling interests recorded a profit for the year.
For the causes, reports said losses at affiliate Lotte Chemical weighed heavily on equity-method results in the first nine months of 2024. The debt ratio rose from 127.1% in 2022 to 139.4% in 2023, 146.3% in 2024 and 144.9% in 2025.
At the end of 2025, total equity was KRW 9.42 trillion, of which the controlling shareholders' stake was KRW 6.08 trillion, and total liabilities were KRW 13.6 trillion.
Operating cash flow was KRW 904.1 billion in 2022, KRW 1.24 trillion in 2023, KRW 1.05 trillion in 2024 and KRW 1.16 trillion in 2025, exceeding KRW 1 trillion in each of the last three years.
Quarterly operating profit moved from KRW 185.1 billion in Q3 2025 to an operating loss of KRW 105.8 billion in Q4 2025, then to KRW 46.1 billion in Q1 2026, KRW 129 billion in Q2 (up 179.9% from the prior quarter) and KRW 157.6 billion in Q3 (up 22.2%), rising for two consecutive quarters.
Net income attributable to controlling shareholders was a loss of KRW 79 billion in Q3 2025 and a loss of KRW 363.7 billion in Q4 2025, turned to a profit of KRW 6.55 billion in Q1 2026, rose to KRW 35.6 billion in Q2, and returned to a loss of KRW 42.1 billion in Q3 2026.
The combined net loss attributable to controlling shareholders over the last four quarters was KRW 363.7 billion. Revenue bottomed at KRW 3.62 trillion in Q1 2026 and rose to KRW 4.09 trillion in Q2 and KRW 4.12 trillion in Q3, although Q3 revenue was 0.7% lower than a year earlier.
The central question in Q3 is that operating profit improved while the bottom-line result turned negative again.